2024 ABAI Continuous Assessment Program - Block Two
The ABAI Continuous Assessment Program serves the need of board certified allergist/immunologists by allowing them to demonstrate their ongoing competence in the field. The program requires allergy/immunology specialists to read and successfully answer three review questions on each of 10 peer reviewed articles in the field every six months, along with correctly answering 10 multiple choice question on core topic areas in the specialty.
Accreditation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of American College of Allergy, Asthma & Immunolgy and The American Board of Allergy and Immunology (ABAI). The American College of Allergy, Asthma & Immunolgy is accredited by the ACCME to provide continuing medical education for physicians.
Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring activity for a maximum of 6 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Target Audience
Board certified allergist/immunologists
Learning Objectives
At the conclusion of this activity, participants should be able to:
1. Outline the major literature published in the specialty during the past 12-24 months
2. Demonstrate mastery of core knowledge central to the practice of allergy/immunology
All relevant financial relationships with ineligible companies have been mitigated.
Len Bacharier, MD, Planner, Test Writer
Consultant: Kinaset, OM Pharma, DBV Technologies, Vertex, Avillion; Speaker: Novartis, AstraZeneca, GlaxoSmithKline, Regeneron, Sanofi; Advisory Board: Regeneron
Priya Bansal, MD, Planner
Advisor: ALK Albello, Amgen, AZ, CSL Behring, Regeneron, Takeda, Teva; Speaker: AZ, Blueprint, CSL Behring, Genentech, GSK, Optinose; Consultant: AZ, GSK
Theresa Bingemann, MD, Planner
Primary investigator: Novartis
Mariana Castells, MD, Planner
Research Grant: Cogent Biosciences, BluePrint; Consultant: Daiichi Sankyo
Christina Ciaccio, MD, Planner
Consultant: ALK, Astra-Zeneca, Genentech, Novartis, Sanofi-Genzyme; Advisory Board: Clostrabio, Siolta
Jeffrey Demain, MD, Planner
Advisory Board: Cogent Biosciences
Luz Fonacier, MD, Test Writer
Advisory Board: Abbvie, Regeneron, Dermavant; Research Grant: Regeneron, Astra Zeneca
Mitchell Grayson, MD, Test Writer
Advisory Board: Bayer HealthCare; Stocks: Invirsa
Hal Hoffman, MD, Planner
Research Grant: Takeda, AB2Bio; Consultant: Novartis
Jay Lieberman, MD, Planner
Advisory Board: Aquestive, DBV; Research Grant: DBV, Regeneron, Aimmune; Adjudication: Abbvie
Giselle Mosnaim, MD, Planner
Research Grant: Sanofi Regeneron, GlaxoSmithKline, Novartis; Consultant: Novartis
Princess Ogbogu, MD, Planner
Advisory Board: Astra Zeneca, GSK, Sanofi; Research Grant: Astra Zeneca, GSK, Blueprint Medical
Miguel A. Park, MD, Test Writer
DSMB: Immunogcnx
Wanda Phipatanakul, MD, Planner
Advisory Board: Astra Zeneca, Genentech, GSK, Novartis, Regeneron/Sanofi, Teva; Research Grant: Alk Abello, Circasso, Lincoln Diagnostics, Monaghen, Regeneron, Thermo Fisher, Genentech/Novartis
Thanai Pongdee, MD, Test Writer
Advisory Board: Blueprint Medicines; Research Grant: GlaxoSmithKline
Jeffrey Stokes, MD, Planner
Research Grant: Regeneron, Sanofi
Dana Wallace, MD, Planner
Consultant: Bryn; Advisory Board: AbbVie
Julie Wang, MD , Planner
Research Grant: Aimmune, DBV Technologies, Siolta; DMC member: ALK Abello
The following have no relevant financial relationships with ineligible companies to disclose:
Andrew Abreo, MD, Test Writer
Karla Adams, MD, Test Writer
Taha Al-Shaikhly, MD, Test Writer
Matt Bell, MD, Test Writer
Denise Diprimio-Kalman, DO, Planner
Katharine Fast, MD, Test Writer
Scott Feldman, MD, PhD, Test Writer
Corinne Keet, MD, Planner
Michael Land, MD, Test Writer
Mitchell Lester, MD, Planner
Aidan Long, MD, Planner
Cecilia Mikita, MD, Test Writer
Anil Nanda, MD, Planner
Michael Nelson, MD, PhD, Planner
Jessica Perkins, MD, Test Writer
Pavadee Poowuttikul, MD, Test Writer
Constantine Saadeh, MD, Test Writer
Rebecca Scherzer, MD, Test Writer
Elizabeth Secord, MD, Test Writer
Kelly Stone, MD, Test Writer
Julie Wendt, MD, Test Writer
Available Credit
- 6.00 AMA PRA Category 1 Credit™
- 6.00 Attendance